Abstract
Major complications of a percutaneous kidney biopsy are infrequent but warrant early detection and appropriate treatment. We herein report a patient who developed urinoma following kidney biopsy in the effort to emphasize the paramount importance for practitioners to recognize this complication. Prompt diagnosis and proper management of urinoma following kidney biopsy is prudent as delayed treatment may lead to abscess formation, hydronephrosis, obstructive uropathy and chronic kidney failure.
References
1.
River GL, Dovenbarger WV, Nikolai TF, Moffat NA: Unusual complications of kidney biopsy. J Urol 1970;103:15-17.
2.
Trehan A, Takhtani D, Singh S, Kumar L: Urinoma - an unusual complication following kidney biopsy. Indian J Pediatr 1998;65:911-913.
3.
Ham YR, Moon KR, Bae HJ, Ju HJ, Jang WI, Choi DE, Na KR, Lee KW, Shin YT: A case of urine leakage: an unusual complication after renal biopsy. Chonnam Med J 2011;47:181-184.
4.
Rianthavorn P, Kerr SJ, Chiengthong K: Safety of paediatric percutaneous native kidney biopsy and factors predicting bleeding complications. Nephrology (Carlton) 2014;19:143-148.
5.
Alsikafi NF, McAninch JW, Elliott SP, Garcia M: Nonoperative management outcomes of isolated urinary extravasation following renal lacerations due to external trauma. J Urol 2006;176:2494-2497.
6.
Titton RL, Gervais DA, Hahn PF, Harisinghani MG, Arellano RS, Mueller PR: Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics 2003;23:1133-1147.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.